Exact Mass: 695.2203628
Exact Mass Matches: 695.2203628
Found 27 metabolites which its exact mass value is equals to given mass value 695.2203628,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dexylosylbenanomicin A
C34H33NO15 (695.1850108000001)
Cefotiam hexetil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Cefotiam hexetil
Elobixibat
C36H45N3O7S2 (695.2698780000001)
1beta,8beta-difuranoyl-4alpha-hydroxy-5alpha,11-diacetoxy-7beta-nicotinoyldihydroagarofuran|triptersinine H
C35H37NO14 (695.2213942000001)
GSK163929B
CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3265; ORIGINAL_PRECURSOR_SCAN_NO 3263 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3281; ORIGINAL_PRECURSOR_SCAN_NO 3278 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3261; ORIGINAL_PRECURSOR_SCAN_NO 3260 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3276; ORIGINAL_PRECURSOR_SCAN_NO 3273 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3269; ORIGINAL_PRECURSOR_SCAN_NO 3267 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3265; ORIGINAL_PRECURSOR_SCAN_NO 3262 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6838; ORIGINAL_PRECURSOR_SCAN_NO 6836 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6880; ORIGINAL_PRECURSOR_SCAN_NO 6878 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6873; ORIGINAL_PRECURSOR_SCAN_NO 6871 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6893; ORIGINAL_PRECURSOR_SCAN_NO 6892 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6899; ORIGINAL_PRECURSOR_SCAN_NO 6897 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6903; ORIGINAL_PRECURSOR_SCAN_NO 6901
DIETHYL (4-{BIS-[4-(DIETHOXY-PHOSPHORYLMETHYL)-PHENYL]-AMINO}-BENZYL)-PHOSPHONATE
Elobixibat
C36H45N3O7S2 (695.2698780000001)
C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation
(2R)-1-[(2E)-2-[(2S)-6-carboxy-2-carboxylato-2,3-dihydro-1H-pyridin-1-ium-4-ylidene]ethylidene]-6-oxido-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-2,3-dihydroindol-1-ium-2-carboxylate
8-chloro-7-[(2S,3R,4S,5R)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-2-oxochromen-4-olate
C35H36ClN2O11- (695.2007516000001)
2,2,2,2-{[4-(9-Anthryl)-2,2:6,2-terpyridine-6,6-diyl]bis(methylenenitrilo)}tetraacetate
C39H29N5O8-4 (695.2016034000001)
2-[[(5S,6S)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid
C34H33NO15 (695.1850108000001)
Xamoterol (hemifumarate)
C16H25N3O5.1/2C4H4O4 (695.1903704)
Xamoterol hemifumarate is a selective and potent agonist of beta1-adrenergic receptor. Xamoterol hemifumarate has the potential for the research of arrhythmogenesis. Xamoterol hemifumarate has the potential for the investigating the relationship between β1-adrenergic stimulation and IKr[1].
(2r)-2-({hydroxy[(5s,6s)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5h,6h-naphtho[1,2-b]anthracen-2-yl]methylidene}amino)propanoic acid
C34H33NO15 (695.1850108000001)